Cognitive decline associated with anesthesia and surgery in the elderlydoes ... contributeto dementia prevalence
B12 in particularto preventdementia / alzeimers
to double every 20 years to more than 80 million cases by 2040(passive) is setPrevalence of dementia
to increase in line with our ageing population , underscoring the need for us as a nation to acknowledge and understand the condition and its impact on individuals and society as a whole(passive) is setDementia prevalence
to rise by more than 70 per cent by 2030(passive) is setDementia prevalence
gram - negative bacilli , in particular that caused by(passive) is caused bya prevalence of dementia
If you do this , you are goingto createdementia " http://www.sciencedaily.com/releases/2009/11/091109194747.htm «
to increase by 50 % by 2020 and 100 % by 2040 ... and therefore further research into the prevention and treatment of Alzheimer ’s disease is neededis setto increase by 50 % by 2020 and 100 % by 2040 ... and therefore further research into the prevention and treatment of Alzheimer ’s disease is needed
to increase over the next 10 yearsis setto increase over the next 10 years
to increase in line with our ageing population , underscoring the need for us as a nation to acknowledge and understand the condition and its impact on individuals and society as a wholeis setto increase in line with our ageing population , underscoring the need for us as a nation to acknowledge and understand the condition and its impact on individuals and society as a whole
which suggested(passive) were influenced bywhich suggested
to rise exponentially together with the prevalence of autism thereby increasing the cost further and demand for servicesis setto rise exponentially together with the prevalence of autism thereby increasing the cost further and demand for services
to more than double in the next yearsis setto more than double in the next years
to this question in the medical industryhas ledto this question in the medical industry
to rise from 885,000 people in 2019 to 1.59 million in 2040is setto rise from 885,000 people in 2019 to 1.59 million in 2040
to more than double in the next 30 - 50 yearsis setto more than double in the next 30 - 50 years
outcomesinfluencedoutcomes
to new therapeutic targetsultimately leadingto new therapeutic targets